Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchPovidone-IodinePovidone-Iod.. (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2

Meister et al., The Journal of Infectious Diseases, doi:10.1093/infdis/jiaa471
Jul 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
PVP-I for COVID-19
13th treatment shown to reduce risk in February 2021, now with p = 0.000000004 from 21 studies.
Lower risk for mortality, cases, and viral clearance.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
In Vitro analysis of 8 oral rinses, showing reduced viral infectivity up to 3 orders of magnitude with povidone-iodine, ethanol + essential oils, and dequalinium chloride + benzalkonium chloride, and log reduction factors ranging from 0.3 to 1.78 for the other 5.
9 preclinical studies support the efficacy of povidone-iodine for COVID-19:
Meister et al., 29 Jul 2020, Germany, peer-reviewed, 12 authors. Contact: eike.steinmann@rub.de.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperPovidone-Iod..All
Abstract: The Journal of Infectious Diseases BRIEF REPORT Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2 Toni Luise Meister,1 Yannick Brüggemann,1 Daniel Todt,1,2 Carina Conzelmann,3 Janis A. Müller,3 Rüdiger Groß,3 Jan Münch,3 Adalbert Krawczyk,4,5 Jörg Steinmann,6,7 Jochen Steinmann,8 Stephanie Pfaender,1,a and Eike Steinmann1,a The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic creates a significant threat to global health. Recent studies suggested the significance of throat and salivary glands as major sites of virus replication and transmission during early coronavirus disease 2019, thus advocating application of oral antiseptics. However, the antiviral efficacy of oral rinsing solutions against SARS-CoV-2 has not been examined. Here, we evaluated the virucidal activity of different available oral rinses against SARS-CoV-2 under conditions mimicking nasopharyngeal secretions. Several formulations with significant SARS-CoV-2 inactivating properties in vitro support the idea that oral rinsing might reduce the viral load of saliva and could thus lower the transmission of SARS-CoV-2. Keywords. SARS-CoV-2; oral rinses; inactivation; suspension test; transmission. The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has created a significant threat to global health. Since effective treatments and vaccines are currently not available, diligent attention on transmission-based precautions is essential to limit viral spread. According to current evidence, SARS-CoV-2 is mainly transmitted through respiratory droplets exhaled from infected individuals [1]. Importantly, viral loads are high in the nasal cavity, nasopharynx, and oropharynx and viral shedding can be detected before, during, and after the acute clinical phase of illness [2]. Aerosols produced Received 18 June 2020; editorial decision 21 July 2020; accepted 24 July 2020; published online July 29, 2020. a S.P. and E.S. are equally contributing last authors. Correspondence: Eike Steinmann, PhD, Department of Molecular and Medical Virology, RuhrUniversity Bochum, Universitaetsstr 150, 44801 Bochum, Germany (eike.steinmann@rub.de). The Journal of Infectious Diseases®  2020;222:1289–92 © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. DOI: 10.1093/infdis/jiaa471 METHODS Virus Strains and Propagation To isolate SARS-CoV-2 at the University Ulm Medical Center (Ulm, Germany), 50 000 Vero E6 cells were seeded in 24-well plates in 500 µL medium incubated overnight at 37°C. The next day, medium was replaced by 400 µL of 2.5 µg/mL amphotericin B–containing medium. Then, 100 µL of throat swabs that tested positive for SARS-CoV-2 by reverse-transcription quantitative polymerase chain reaction was titrated 5-fold on the cells and incubated for 3–5 days. Upon visible cytopathic effect, supernatant was taken and virus expanded by inoculation of Vero E6 cells in 75 cm2 flasks and propagated as described above. Thereby, the viral isolates BetaCoV/Germany/Ulm/01/2020 (strain 2) and BetaCoV/Germany/Ulm/02/2020 (strain 3) were obtained. In Essen, Germany, SARS-CoV-2 was isolated from a nasopharyngeal swab of a patient suffering from coronavirus disease 2019 (COVID-19) and named UKEssen strain (strain 1). The swab was taken using a Virocult vial (Sigma, Germany). The..
{ 'indexed': {'date-parts': [[2023, 2, 21]], 'date-time': '2023-02-21T21:10:58Z', 'timestamp': 1677013858453}, 'reference-count': 10, 'publisher': 'Oxford University Press (OUP)', 'issue': '8', 'license': [ { 'start': { 'date-parts': [[2020, 7, 29]], 'date-time': '2020-07-29T00:00:00Z', 'timestamp': 1595980800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model'}], 'funder': [ { 'name': 'European Union’s Horizon 2020 research and innovation program', 'award': ['101003555']}, {'name': 'International Graduate School in Molecular Medicine Ulm'}, { 'DOI': '10.13039/501100010380', 'name': 'Stiftung Universitätsmedizin Essen', 'doi-asserted-by': 'publisher'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2020, 9, 14]]}, 'abstract': '<jats:title>Abstract</jats:title>\n' ' <jats:p>The ongoing severe acute respiratory syndrome coronavirus 2 ' '(SARS-CoV-2) pandemic creates a significant threat to global health. Recent studies suggested ' 'the significance of throat and salivary glands as major sites of virus replication and ' 'transmission during early coronavirus disease 2019, thus advocating application of oral ' 'antiseptics. However, the antiviral efficacy of oral rinsing solutions against SARS-CoV-2 has ' 'not been examined. Here, we evaluated the virucidal activity of different available oral ' 'rinses against SARS-CoV-2 under conditions mimicking nasopharyngeal secretions. Several ' 'formulations with significant SARS-CoV-2 inactivating properties in vitro support the idea ' 'that oral rinsing might reduce the viral load of saliva and could thus lower the transmission ' 'of SARS-CoV-2.</jats:p>', 'DOI': '10.1093/infdis/jiaa471', 'type': 'journal-article', 'created': {'date-parts': [[2020, 7, 24]], 'date-time': '2020-07-24T19:12:10Z', 'timestamp': 1595617930000}, 'page': '1289-1292', 'source': 'Crossref', 'is-referenced-by-count': 117, 'title': 'Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome ' 'Coronavirus 2', 'prefix': '10.1093', 'volume': '222', 'author': [ { 'given': 'Toni Luise', 'family': 'Meister', 'sequence': 'first', 'affiliation': [ { 'name': 'Department for Molecular and Medical Virology, Ruhr University ' 'Bochum, Bochum, Germany'}]}, { 'given': 'Yannick', 'family': 'Brüggemann', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department for Molecular and Medical Virology, Ruhr University ' 'Bochum, Bochum, Germany'}]}, { 'given': 'Daniel', 'family': 'Todt', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department for Molecular and Medical Virology, Ruhr University ' 'Bochum, Bochum, Germany'}, {'name': 'European Virus Bioinformatics Center, Jena, Germany'}]}, { 'given': 'Carina', 'family': 'Conzelmann', 'sequence': 'additional', 'affiliation': [ { 'name': 'Institute of Molecular Virology, Ulm University Medical Center, ' 'Ulm, Germany'}]}, { 'given': 'Janis A', 'family': 'Müller', 'sequence': 'additional', 'affiliation': [ { 'name': 'Institute of Molecular Virology, Ulm University Medical Center, ' 'Ulm, Germany'}]}, { 'given': 'Rüdiger', 'family': 'Groß', 'sequence': 'additional', 'affiliation': [ { 'name': 'Institute of Molecular Virology, Ulm University Medical Center, ' 'Ulm, Germany'}]}, { 'given': 'Jan', 'family': 'Münch', 'sequence': 'additional', 'affiliation': [ { 'name': 'Institute of Molecular Virology, Ulm University Medical Center, ' 'Ulm, Germany'}]}, { 'given': 'Adalbert', 'family': 'Krawczyk', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Infectious Diseases, West German Centre of ' 'Infectious Diseases, Universitätsmedizin Essen, University ' 'Duisburg-Essen, Essen, Germany'}, { 'name': 'Institute for Virology, University Hospital Essen, University of ' 'Duisburg-Essen, Essen, Germany'}]}, { 'given': 'Jörg', 'family': 'Steinmann', 'sequence': 'additional', 'affiliation': [ { 'name': 'Institute of Clinical Hygiene, Medical Microbiology and ' 'Infectiology, General Hospital Nürnberg, Paracelsus Medical ' 'University, Nuremberg, Germany'}, { 'name': 'Institute of Medical Microbiology, University Hospital of Essen, ' 'Essen, Germany'}]}, { 'given': 'Jochen', 'family': 'Steinmann', 'sequence': 'additional', 'affiliation': [ { 'name': 'Dr. Brill + Partner GmbH Institute for Hygiene and Microbiology, ' 'Bremen, Germany'}]}, { 'given': 'Stephanie', 'family': 'Pfaender', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department for Molecular and Medical Virology, Ruhr University ' 'Bochum, Bochum, Germany'}]}, { 'given': 'Eike', 'family': 'Steinmann', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department for Molecular and Medical Virology, Ruhr University ' 'Bochum, Bochum, Germany'}]}], 'member': '286', 'published-online': {'date-parts': [[2020, 7, 29]]}, 'reference': [ { 'key': '2020100312232117200_CIT0001', 'doi-asserted-by': 'crossref', 'first-page': '2061', 'DOI': '10.1056/NEJMc2007800', 'article-title': 'Visualizing speech-generated oral fluid droplets with laser light ' 'scattering', 'volume': '382', 'author': 'Anfinrud', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '2020100312232117200_CIT0002', 'doi-asserted-by': 'crossref', 'first-page': '465', 'DOI': '10.1038/s41586-020-2196-x', 'article-title': 'Virological assessment of hospitalized patients with COVID-2019', 'volume': '581', 'author': 'Wölfel', 'year': '2020', 'journal-title': 'Nature'}, { 'key': '2020100312232117200_CIT0003', 'doi-asserted-by': 'crossref', 'first-page': '2063', 'DOI': '10.1056/NEJMc2009324', 'article-title': 'Droplets and aerosols in the transmission of SARS-CoV-2', 'volume': '382', 'author': 'Meselson', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '2020100312232117200_CIT0004', 'doi-asserted-by': 'crossref', 'first-page': '1592', 'DOI': '10.3201/eid2607.200915', 'article-title': 'Inactivation of severe acute respiratory syndrome coronavirus 2 by ' 'WHO-recommended hand rub formulations and alcohols', 'volume': '26', 'author': 'Kratzel', 'year': '2020', 'journal-title': 'Emerging Infect Dis'}, { 'key': '2020100312232117200_CIT0005', 'doi-asserted-by': 'crossref', 'first-page': 'zqaa002', 'DOI': '10.1093/function/zqaa002', 'article-title': 'Potential role of oral rinses targeting the viral lipid envelope in ' 'SARS-CoV-2 infection', 'volume': '1', 'author': 'O’Donnell', 'year': '2020', 'journal-title': 'Function'}, { 'key': '2020100312232117200_CIT0006', 'first-page': '492', 'article-title': 'How effective is washing hands against influenza viruses? [in German]', 'author': 'Eggers', 'year': '2009', 'journal-title': 'Hyg Med'}, { 'key': '2020100312232117200_CIT0007', 'doi-asserted-by': 'crossref', 'first-page': '249', 'DOI': '10.1007/s40121-018-0200-7', 'article-title': 'In vitro bactericidal and virucidal efficacy of povidone-iodine ' 'gargle/mouthwash against respiratory and oral tract pathogens', 'volume': '7', 'author': 'Eggers', 'year': '2018', 'journal-title': 'Infect Dis Ther'}, { 'key': '2020100312232117200_CIT0008', 'doi-asserted-by': 'crossref', 'first-page': '442', 'DOI': '10.1016/S1079-2104(05)80124-6', 'article-title': 'The antiviral spectrum of Listerine antiseptic', 'volume': '79', 'author': 'Dennison', 'year': '1995', 'journal-title': 'Oral Surg Oral Med Oral Pathol Oral Radiol Endod'}, { 'key': '2020100312232117200_CIT0009', 'doi-asserted-by': 'crossref', 'first-page': '341', 'DOI': '10.1111/j.1600-051X.2005.00673.x', 'article-title': 'Efficacy of Listerine antiseptic in reducing viral contamination of ' 'saliva', 'volume': '32', 'author': 'Meiller', 'year': '2005', 'journal-title': 'J Clin Periodontol'}, { 'key': '2020100312232117200_CIT0010', 'first-page': '23', 'article-title': 'Efficacy of Listerine antiseptic against MRSA, Candida albicans and HIV', 'volume': '35', 'author': 'Yamanaka', 'year': '1994', 'journal-title': 'Bull Tokyo Dent Coll'}], 'container-title': 'The Journal of Infectious Diseases', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'http://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiaa471/33652398/jiaa471.pdf', 'content-type': 'application/pdf', 'content-version': 'am', 'intended-application': 'syndication'}, { 'URL': 'http://academic.oup.com/jid/article-pdf/222/8/1289/33834016/jiaa471.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'syndication'}, { 'URL': 'http://academic.oup.com/jid/article-pdf/222/8/1289/33834016/jiaa471.pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2020, 10, 3]], 'date-time': '2020-10-03T16:23:37Z', 'timestamp': 1601742217000}, 'score': 1, 'resource': {'primary': {'URL': 'https://academic.oup.com/jid/article/222/8/1289/5878067'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 7, 29]]}, 'references-count': 10, 'journal-issue': { 'issue': '8', 'published-online': {'date-parts': [[2020, 7, 29]]}, 'published-print': {'date-parts': [[2020, 9, 14]]}}, 'URL': 'http://dx.doi.org/10.1093/infdis/jiaa471', 'relation': {}, 'ISSN': ['0022-1899', '1537-6613'], 'subject': ['Infectious Diseases', 'Immunology and Allergy'], 'published-other': {'date-parts': [[2020, 10, 15]]}, 'published': {'date-parts': [[2020, 7, 29]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit